EA032315B1 - Замещенные трициклические гетероциклические соединения - Google Patents

Замещенные трициклические гетероциклические соединения Download PDF

Info

Publication number
EA032315B1
EA032315B1 EA201792034A EA201792034A EA032315B1 EA 032315 B1 EA032315 B1 EA 032315B1 EA 201792034 A EA201792034 A EA 201792034A EA 201792034 A EA201792034 A EA 201792034A EA 032315 B1 EA032315 B1 EA 032315B1
Authority
EA
Eurasian Patent Office
Prior art keywords
phenyl
dihydro
imidazo
pyridin
formula
Prior art date
Application number
EA201792034A
Other languages
English (en)
Russian (ru)
Other versions
EA201792034A1 (ru
Inventor
Хай-Юнь Сяо
Т.Г. Мурали Дхар
Цзиньву Дуань
Бинь Цзян
Эндрю Дж. Теббен
Original Assignee
Бристол-Маерс Сквибб Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бристол-Маерс Сквибб Компани filed Critical Бристол-Маерс Сквибб Компани
Publication of EA201792034A1 publication Critical patent/EA201792034A1/ru
Publication of EA032315B1 publication Critical patent/EA032315B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epidemiology (AREA)
EA201792034A 2015-03-18 2016-03-17 Замещенные трициклические гетероциклические соединения EA032315B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562134769P 2015-03-18 2015-03-18
PCT/US2016/022737 WO2016149436A1 (en) 2015-03-18 2016-03-17 Substituted tricyclic heterocyclic compounds

Publications (2)

Publication Number Publication Date
EA201792034A1 EA201792034A1 (ru) 2018-03-30
EA032315B1 true EA032315B1 (ru) 2019-05-31

Family

ID=55640932

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201792034A EA032315B1 (ru) 2015-03-18 2016-03-17 Замещенные трициклические гетероциклические соединения

Country Status (14)

Country Link
US (1) US10189840B2 (enExample)
EP (1) EP3271360B1 (enExample)
JP (1) JP6793657B2 (enExample)
KR (1) KR102654709B1 (enExample)
CN (1) CN107635993B (enExample)
AU (1) AU2016233288A1 (enExample)
BR (1) BR112017019773A2 (enExample)
CA (1) CA2980159A1 (enExample)
EA (1) EA032315B1 (enExample)
ES (1) ES2797805T3 (enExample)
IL (1) IL254424A0 (enExample)
MX (1) MX2017011434A (enExample)
SG (1) SG11201707469WA (enExample)
WO (1) WO2016149436A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6793658B2 (ja) 2015-03-18 2020-12-02 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ Ｔｎｆ阻害剤として有用な三環式ヘテロ環式化合物
MX2017011577A (es) 2015-03-18 2017-10-26 Bristol Myers Squibb Co Compuestos heterociclicos utiles como inhibidores de factor de necrosis tumoral (tnf).
UY36628A (es) 2015-04-17 2016-11-30 Abbvie Inc Indazolonas como moduladores de la señalización de tnf
US20160304496A1 (en) 2015-04-17 2016-10-20 Abbvie Inc. Indazolones as modulators of tnf signaling
WO2016168641A1 (en) 2015-04-17 2016-10-20 Abbvie Inc. Tricyclic modulators of tnf signaling
GB201510758D0 (en) 2015-06-18 2015-08-05 Ucb Biopharma Sprl Novel TNFa structure for use in therapy
CN108137609B (zh) 2015-08-03 2021-07-16 百时美施贵宝公司 用作TNFα的调节剂的环状化合物
GB201621907D0 (en) 2016-12-21 2017-02-01 Ucb Biopharma Sprl And Sanofi Antibody epitope
JP7121033B2 (ja) * 2017-03-15 2022-08-17 ユーシービー バイオファルマ エスアールエル Ｔｎｆ活性のモジュレーターとしての縮合五環式イミダゾール誘導体

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013186229A1 (en) * 2012-06-11 2013-12-19 Ucb Pharma S.A. Tnf -alpha modulating benzimidazoles

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6038397B2 (ja) * 1980-03-06 1985-08-31 エスエス製薬株式会社 チアジノイミダゾ−ル誘導体及びその製造法
EP0963371B1 (en) 1997-02-25 2003-05-02 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase
DE60024480T2 (de) * 1999-10-27 2006-07-27 Novartis Ag Thiazol und imidazo[4,5-b]pyridin verbindungen und ihre verwendung als pharmazeutika
US7601846B2 (en) 2001-06-26 2009-10-13 The Regents Of The University Of California Compounds having activity as inhibitors of apoptosis
CN1633434A (zh) 2002-01-31 2005-06-29 第一制药株式会社 咪唑并[1,2－a]吡啶衍生物
AU2003298839A1 (en) 2002-12-03 2004-06-23 Isis Pharmaceuticals, Inc. Benzimidazoles and analogs thereof as antivirals
US20050124638A1 (en) 2003-12-08 2005-06-09 Swayze Eric E. Benzimidazoles and analogs thereof as antivirals
CN101687865A (zh) * 2007-06-26 2010-03-31 塞诺菲-安万特股份有限公司 稠合的苯并咪唑和氮杂苯并咪唑的区域选择性金属催化合成
FR2919610B1 (fr) * 2007-08-02 2009-10-16 Sanofi Aventis Sa Derives de n-heteroaryl-carboxamides tricycliques,leur preparation et leur application en therapeutique
EP2209785A1 (en) 2007-10-05 2010-07-28 S*BIO Pte Ltd 2-morpholinylpurines as inhibitors of pi3k
JP2009227599A (ja) 2008-03-21 2009-10-08 Daiichi Sankyo Co Ltd イミダゾピリダジン誘導体
CN101717397B (zh) 2008-10-09 2012-11-28 中国科学院上海药物研究所 一类取代吡啶并[2',1':2,3]咪唑并[4,5-c]异喹啉酮类化合物及其合成方法和用途,以及包含该类化合物的药物组合物
SG171815A1 (en) * 2008-12-19 2011-07-28 Bristol Myers Squibb Co Carbazole carboxamide compounds useful as kinase inhibitors
US8691187B2 (en) 2009-03-23 2014-04-08 Eli Lilly And Company Imaging agents for detecting neurological disorders
CN102438660A (zh) 2009-03-23 2012-05-02 美国西门子医疗解决公司 用于检测神经障碍的显像剂
WO2012148550A1 (en) 2011-02-25 2012-11-01 Myrexis, Inc. Prodrugs of therapeutic compounds
EP2527344A1 (en) 2011-05-25 2012-11-28 Almirall, S.A. Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
GB201212513D0 (en) 2012-07-13 2012-08-29 Ucb Pharma Sa Therapeutic agents
JP6259823B2 (ja) 2012-07-13 2018-01-10 ユーシービー バイオファルマ エスピーアールエル Ｔｎｆ活性の調節物質としてのイミダゾピリジン誘導体
WO2015086523A1 (en) 2013-12-09 2015-06-18 Ucb Biopharma Sprl Fused bicyclic heteroaromatic derivatives as modulators of tnf activity
GB201321737D0 (en) 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic Agents
GB201321739D0 (en) 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
GB201321742D0 (en) 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
GB201321746D0 (en) 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
JP6469692B2 (ja) 2013-12-09 2019-02-13 ユーシービー バイオファルマ エスピーアールエル Ｔｎｆ活性のモジュレーターとしてのイミダゾピリジン誘導体
GB201321741D0 (en) 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
GB201321735D0 (en) 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic Agents
GB201321743D0 (en) 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
GB201321738D0 (en) 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic Agents
GB201321744D0 (en) 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
GB201321745D0 (en) 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
CA2963639C (en) 2014-10-06 2023-07-04 Signal Pharmaceuticals, Llc Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
JP6793658B2 (ja) 2015-03-18 2020-12-02 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ Ｔｎｆ阻害剤として有用な三環式ヘテロ環式化合物
MX2017011577A (es) 2015-03-18 2017-10-26 Bristol Myers Squibb Co Compuestos heterociclicos utiles como inhibidores de factor de necrosis tumoral (tnf).

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013186229A1 (en) * 2012-06-11 2013-12-19 Ucb Pharma S.A. Tnf -alpha modulating benzimidazoles

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ALBA CHIMIRRI, PIETRO MONFORTE, LAURA MUSUMECI, ANGELA RAO, MARIA ZAPPAL�, ANNA-MARIA MONFORTE: "Synthesis and Antitumour Activity of 1H,3H-Thiazolo[3,4-a]benzimidazole Derivatives", ARCHIV DER PHARMAZIE, VCH VERLAGSGESELLSCHAFT MBH, �ETC.|, vol. 334, no. 6, 1 June 2001 (2001-06-01), pages 203 - 208, XP055178332, ISSN: 03656233, DOI: 10.1002/1521-4184(200106)334:6<203::AID-ARDP203>3.0.CO;2-L *

Also Published As

Publication number Publication date
CN107635993B (zh) 2020-05-22
US10189840B2 (en) 2019-01-29
EP3271360B1 (en) 2020-04-22
CN107635993A (zh) 2018-01-26
US20180111936A1 (en) 2018-04-26
EA201792034A1 (ru) 2018-03-30
KR102654709B1 (ko) 2024-04-03
IL254424A0 (en) 2017-11-30
JP6793657B2 (ja) 2020-12-02
JP2018508553A (ja) 2018-03-29
BR112017019773A2 (pt) 2018-05-15
KR20170129810A (ko) 2017-11-27
ES2797805T3 (es) 2020-12-03
EP3271360A1 (en) 2018-01-24
WO2016149436A1 (en) 2016-09-22
SG11201707469WA (en) 2017-10-30
CA2980159A1 (en) 2016-09-22
MX2017011434A (es) 2018-01-25
AU2016233288A1 (en) 2017-11-09

Similar Documents

Publication Publication Date Title
EA032315B1 (ru) Замещенные трициклические гетероциклические соединения
CN102892759B (zh) 具有犬尿氨酸产生抑制作用的含氮杂环化合物
KR20210003103A (ko) 치환된 4-아미노이소인돌린-1,3-디온 화합물 및 림프종의 치료를 위한 이의 용도
JP2021535207A (ja) 甲状腺ホルモン受容体ベータアゴニスト化合物
JP7571276B2 (ja) ヒストン脱アセチル化酵素６阻害剤としての新規な構造の化合物およびこれを含む薬剤学的組成物
CA3082735A1 (en) Substituted macrocyclic indole derivatives
JP2011517440A (ja) 中枢神経系障害を処置するためのアザインドール化合物
CN109071548A (zh) 可用于治疗尤其是癌症的吡咯并咪唑衍生物或其类似物
EP4183781A1 (en) Sulfur-containing isoindoline derivative, and preparation method therefor and medical use thereof
EA032314B1 (ru) Трициклические гетероциклические соединения, применимые в качестве ингибиторов tnf
JP2023525116A (ja) 免疫調節剤としてのビアリール環結合芳香族複素環誘導体の調製およびその適用
CN113574058A (zh) 吲哚类大环衍生物、其制备方法及其在医药上的应用
CN116669736A (zh) 稠杂环基取代的环己二酰亚胺衍生物、其制备方法及其在医药上的应用
CN108779100B (zh) 3,4-二吡啶基吡唑类衍生物、其制备方法及其在医药上的应用
CN106604918B (zh) 多环hERG激活剂
CN113518779A (zh) 噻吩并杂环类衍生物、其制备方法及其在医药上的应用
KR20240088970A (ko) 소듐 채널 활성화제로서 피리딘 유도체 및 이의 용도
TWI848162B (zh) 橋雜環基取代的嘧啶類化合物及其製備方法和醫藥用途
KR20200083545A (ko) 치환된 페닐 설폰일 페닐 트리아졸 싸이온 및 이의 용도
CA3149302A1 (en) Substituted cyclopropyl-2,2&#39;-bipyrimidinyl compounds, analogues thereof, and methods using same
JP7729632B2 (ja) 新規三環芳香族複素環化合物、ならびにその調製方法、医薬組成物および適用
CN103958484B (zh) 噁唑烷酮类衍生物、其制备方法及其在医药上的应用
WO2011070299A1 (fr) DERIVES DE 9H-BETA-CARBOLINE (OU 9H-PYRIDINO[3,4-b]INDOLE) TRISUBSTITUES, LEUR PREPARATION ET LEUR UTILISATION THERAPEUTIQUE
RU2847441C1 (ru) Серосодержащее производное изоиндолина, способ его получения и его медицинское применение
WO2024217481A1 (zh) Egfr降解剂、其药物组合物及其用途

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM RU